SNOA

0.78% 0.0199

Handel nachbörslich: 2.62 0.04 +1.55%

Sonoma Pharmaceuticals Inc (SNOA)

Überblick Nachrichten Preisverlauf Financials Warum fällt SNOA? Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Sonoma Pharmaceuticals Inc Stock (SNOA) Company Profile

Sonoma Pharmaceuticals Inc

Healthcare (1196)

800-759-9305

5445 CONESTOGA COURT, SUITE 150, BOULDER, CA

Nächster Verdiensttermin

Neueste SEC-Einreichungen

SNOA's Discussions on Twitter

Vergleichen Sie SNOA mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
SNOA	2.58	3.41M	12.31M	-5.08M	-5.20M	-1.52
ZTS	176.42	79.51B	9.15B	2.43B	2.31B	4.92
TAK	13.53	42.89B	30.27B	1.93B	3.45B	0.444
HLN	9.43	42.57B	14.26B	1.55B	0	0.3327
TEVA	16.49	18.51B	16.77B	-959.00M	1.37B	-2.00
VTRS	13.00	15.37B	15.24B	-646.50M	1.88B	1.53

Sonoma Pharmaceuticals Inc Aktie (SNOA) Neueste Nachrichten

Finanzdaten der Sonoma Pharmaceuticals Inc-Aktie (SNOA)

Sonoma Pharmaceuticals Inc (SNOA)

Sonoma Pharmaceuticals Inc Stock (SNOA) Company Profile

Vergleichen Sie SNOA mit anderen Aktien

Sonoma Pharmaceuticals Inc Aktie (SNOA) Neueste Nachrichten

AMGN Stock Drops 5% Amid Industry Decline and Earnings Report - GuruFocus.com

Siga Technologies (SIGA) Sees Significant Stock Decline Amidst P - GuruFocus.com

Sonoma Pharmaceuticals gains FDA clearance for hydrogel By Investing.com - Investing.com Australia

Sonoma Pharmaceuticals (NASDAQ:SNOA) Share Price Passes Above Two Hundred Day Moving Average – Here’s Why - Defense World

Sonoma Pharmaceuticals gains FDA clearance for hydrogel - Investing.com India

Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance for Microcyn(R)-based Wound Care Hydrogel - AccessWire

Pre-market Movers: REVB, CDIO, SMLR, DWTX... - RTTNews

Sonoma Pharmaceuticals Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance

Sonoma Pharmaceuticals Inc. (SNOA) Quarterly 10-Q Report - Quartzy

Sonoma Pharmaceuticals Inc (SNOA) Quarterly 10-Q Report - Quartzy

Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2025 Financial Results - AccessWire

Certain Options of Sonoma Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 29-JAN-2020. - Marketscreener.com

Certain Restricted Stock Units of Sonoma Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 29-JAN-2020. - Marketscreener.com

Certain Warrants of Sonoma Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 29-JAN-2020. - Marketscreener.com

Certain Preferred stock of Sonoma Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 29-JAN-2020. - Marketscreener.com

Sonoma Pharmaceuticals to Exhibit at MEDICA 2024 in Düsseldorf - AccessWire

Sonoma Pharmaceuticals, Inc. to Exhibit At MEDICA 2024 in Dusseldorf - Marketscreener.com

Sonoma Pharmaceuticals (SNOA) Surges Amid Positive Analyst Ratin - GuruFocus.com

Unveiling the Future: Animal Wound Care Market to USD 1.24 BILLION IN 2023, Forecast by 2030, Featuring a C... - WhaTech

Sonoma Pharmaceuticals Announces Expanded Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in Canada - AccessWire

Sonoma Pharmaceuticals to Present at Danisavage Financial Strategies, and LD Micro Main Event XVII Investor Conferences - AccessWire

Scar Treatment Market to See Booming Growth 2024-2031 | Bausch - openPR

Keloid Treatment Market Latest Report 2023-2031 - InsightAce Analytic

Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) Stock's 43% Dive Might Signal An Opportunity But It Requires Some Scrutiny - Simply Wall St

Recent Developments in the Eye Skin Care Market - openPR

Keloid Treatment Market: Insights Predicting a $4.72 Billion Valuation by 2031 - WhaTech

Hypertrophic Scar Treatment Market Growth, Trends, and Industry Share Analysis (2024-2032) - News in Assen

Sonoma Pharmaceuticals (SNOA) Shares Surge Amid Positive Market Activity - GuruFocus.com

Sonoma Pharmaceuticals (NASDAQ:SNOA) Stock Price Crosses Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat

Williams-Sonoma, Inc. (WSM) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance

South Korea Topical scar treatment Market Size & Outlook, 2030 - Grand View Research

Mexico Topical scar treatment Market Size & Outlook, 2030 - Grand View Research

Scar Treatment Market Top Industry Players – Perrigo Company, Smith & Nephew, Alliance Pharma, Rej√ªvaskin - Cauverynews

Sonoma Pharmaceuticals (SNOA) Stock Rises Amid Financial Report Insights - GuruFocus.com

Williams-Sonoma (WSM) Dips More Than Broader Market: What You Should Know - Yahoo Finance

Scar Management Market Set to Grow at 5.61% CAGR, Projected to Reach $1.64 Billion by 2031 - WhaTech

U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.86% - MSN

Sonoma Pharmaceuticals (NASDAQ:SNOA) Stock Passes Above 200-Day Moving Average of $0.56 - MarketBeat

Here's Why Williams-Sonoma (WSM) Gained But Lagged the Market Today - Yahoo Finance

TNF Pharmaceuticals (NASDAQ:TNFA) Stock Quotes, Forecast and News Summary - Benzinga

Sonoma County will receive $43 million in opioid settlements. How should it be spent? - The Santa Rosa Press Democrat

SONO’s latest rating updates from top analysts. - Knox Daily

Top investors say Sonos Inc (SONO) ticks everything they need - SETE News

15,500 Shares in Sonoco Products (NYSE:SON) Acquired by Skandinaviska Enskilda Banken AB publ - Defense World

Federated Hermes Inc. Sells 466 Shares of Sonoco Products (NYSE:SON) - Defense World

Intubation Tubes Market Report Details Growth Drivers, Opportunities, Share Report And Forecast To 2033 - WhaTech

Hypertrophic And Keloid Scar Treatment Market Advancements Highlighted by Size, Growth,Outlook Report 2033 - WhaTech

Scar Treatment Global Market Report 2024: Growth Drivers and Dynamics 2033 - WhaTech

Sei Investments Co. Has $75.60 Million Position in Sonoco Products (NYSE:SON) - Defense World

Ameritas Investment Partners Inc. Reduces Stock Position in Sonoco Products (NYSE:SON) - Defense World

Sonoma Pharmaceuticals regains compliance with Nasdaq minimum bid price rule - MSN

Finanzdaten der Sonoma Pharmaceuticals Inc-Aktie (SNOA)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie SNOA